产品信息
参考资料(来源文献)
| 背景描述 | established from the bone marrow of a 31-year-old woman with acute myeloid leukemia (AML FAB M5a) at 2nd relapse; described in the literature to show strong lysozyme activity in the cytoplasm, phagocytic activities, and cells are responsive to induction of differentiation with TPA; cells carry the t(9;11)(p22;q23) KMT2A-MLLT3 (MLL-MLLT3; MLL-AF9) alteration. |
| 年龄（性别） | 女性；31岁 |
| 组织来源 | 骨髓 |
| 细胞类型 | 肿瘤细胞 |
| 肿瘤类型 | 急性髓系白血病 |
| 生物安全等级 | BSL-1 |
| 倍增时间 | 48 hours |
| 保藏机构 | DSMZ; ACC-542 |
FAQs
Q：{{item.question}}
A：{{item.answer}}
暂无数据
